Comparative efficacy of enrofloxacin to that of tulathromycin for the control of bovine respiratory disease and prevalence of antimicrobial resistance in &ITMannheimia haemolytica&IT in calves at high risk of developing bovine respiratory disease

被引:24
|
作者
Crosby, S. [1 ]
Credille, B. [1 ]
Giguere, S. [2 ]
Berghaus, R. [1 ]
机构
[1] Univ Georgia, Coll Vet Med, Food Anim Hlth & Management Program, Athens, GA 30602 USA
[2] Univ Georgia, Coll Vet Med, Dept Large Anim Med, Athens, GA 30602 USA
关键词
antimicrobial resistance; bovine respiratory disease; enrofloxacin; Mannheimia haemolytica; tulathromycin; EPITHELIAL LINING FLUID; FEEDLOT CATTLE; LUNG-TISSUE; MANNHEIMIA-HAEMOLYTICA; STOCKER CATTLE; PHARMACOKINETICS; TILMICOSIN; DRUG; PHARMACODYNAMICS; METAANALYSIS;
D O I
10.1093/jas/sky054
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
Bovine respiratory disease (BRD) is the most common cause of morbidity and mortality in North American beef cattle. Mannheimia haemolytica is the bacterial pathogen most often isolated from cattle with BRD, and the prevalence of antimicrobial resistance (AMR) in this organism has increased in recent years. Antimicrobials are commonly used to prevent BRD in cattle at high risk of developing BRD; however, recent work would suggest that this practice might be one factor contributing to the increased prevalence of AMR in M. haemolytica. We hypothesized that the administration of the short-acting fluoroquinolone, enrofloxacin, would be just as effective as the long-acting triamilide, tulathromycin, in preventing BRD but would be less likely to select for AMR M. haemolytica in stocker calves at high risk of developing BRD. Three hundred forty-one stocker calves were enrolled in the study with 172 calves in 4 pens being randomly assigned to treatment with enrofloxacin and 169 calves in 4 pens randomly assigned to treatment with tulathromycin. Calves within each treatment group were allocated to one of 4 replicate pens based on the week of enrollment. Of calves receiving enrofloxacin, 33.7% required treatment for BRD at least once within 45 d after arrival, compared with 18.3% of calves receiving tulathromycin (P = 0.040). The percentages of calves that required more than one treatment for BRD within 45 d after arrival did not differ statistically for those receiving enrofloxacin compared with those receiving tulathromycin (10.5% and 4.7%, respectively; P = 0.107) Likewise, the percentages of calves that died during the 45-d follow-up period did not differ for those receiving enrofloxacin compared with those receiving tulathromycin (12.2% and 10.1%, respectively; P = 0.592). Mannheimia haemolytica was cultured from 11% of calves sampled at arrival and from 50% of calves sampled at revaccination 14 to 17 d later. There was a significanst effect of sampling time on the proportion of calves carrying multidrug-resistant (MDR) isolates, with calves having a higher prevalence of MDR isolates at revaccination than arrival (100% vs. 13%; P < 0.001). Future research evaluating the impact of MDR on response to antimicrobial therapy is necessary.
引用
收藏
页码:1259 / 1267
页数:9
相关论文
共 50 条
  • [31] Comparative Efficacy of Tulathromycin vs. Florfenicol/Flunixin Combination in Bovine Respiratory Disease (BRD) Associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni, on Italian Commercial Farms
    Nanjiani, I. A.
    Basano, Solari F.
    Nazzari, R.
    Toni, F.
    Miotto, L.
    CATTLE PRACTICE, 2010, 18 : 38 - 39
  • [32] Estimating the comparative clinical and economic consequences of tulathromycin for treatment of present or anticipated outbreaks of bovine respiratory disease in feedlot cattle in the United States
    Nautrup, B. Poulsen
    Van Vlaenderen, I.
    Gasper, S. M.
    Holland, R. E.
    JOURNAL OF ANIMAL SCIENCE, 2013, 91 (12) : 5868 - 5877
  • [33] An Evaluation of Concomitant Therapy for the Treatment of Arrival Fever in Feedlot Calves at Ultra-High Risk of Developing Undifferentiated Fever/Bovine Respiratory Disease
    Booker, Calvin W.
    Perrett, Tye
    Fenton, R. Kent
    Behlke, Eric J.
    Hannon, Sherry J.
    Wildman, Brian K.
    Rademacher, Ryan D.
    McMullen, Christopher A.
    Hunsaker, Breck D.
    Hill, Travis
    Jim, G. Kee
    INTERNATIONAL JOURNAL OF APPLIED RESEARCH IN VETERINARY MEDICINE, 2017, 15 (02): : 85 - 98
  • [34] Control, Management, and Prevention of Bovine Respiratory Disease in Dairy Calves and Cows
    Gorden, Patrick J.
    Plummer, Paul
    VETERINARY CLINICS OF NORTH AMERICA-FOOD ANIMAL PRACTICE, 2010, 26 (02) : 243 - +
  • [35] Prevalence and antimicrobial susceptibility of Mycoplasma bovis from the upper and lower respiratory tracts of healthy feedlot cattle and those diagnosed with bovine respiratory disease
    Sultana, Razia
    Cordeiro, Roniele P.
    Timsit, Edouard
    Mcallister, Tim A.
    Alexander, Trevor W.
    VETERINARY MICROBIOLOGY, 2023, 285
  • [36] Agreement of antimicrobial susceptibility testing of Pasteurella multocida and Mannheimia haemolytica isolates from preweaned dairy calves with bovine respiratory disease
    Credille, Brent C.
    Capik, Sarah F.
    Credille, Allison
    Crossley, Beate M.
    Blanchard, Pat
    Woolums, Amelia R.
    Lehenbauer, Terry W.
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 2023, 84 (11)
  • [37] Limitations of bacterial culture, viral PCR, and tulathromycin susceptibility from upper respiratory tract samples in predicting clinical outcome of tulathromycin control or treatment of bovine respiratory disease in high-risk feeder heifers
    Sarchet, Jeffrey J.
    Pollreisz, John P.
    Bechtol, David T.
    Blanding, Mitchell R.
    Saltman, Roger L.
    Taube, Patrick C.
    PLOS ONE, 2022, 17 (02):
  • [38] Evaluation of multiple ancillary therapies used in combination with an antimicrobial in newly received high-risk calves treated for bovine respiratory disease
    Wilson, B. K.
    Step, D. L.
    Maxwell, C. L.
    Wagner, J. J.
    Richards, C. J.
    Krehbiel, C. R.
    JOURNAL OF ANIMAL SCIENCE, 2015, 93 (07) : 3661 - 3674
  • [39] Prevalence and temporal trends in antimicrobial resistance of bovine respiratory disease pathogen isolates submitted to the Wisconsin Veterinary Diagnostic Laboratory: 2008-2017
    Holschbach, C. L.
    Aulik, N.
    Poulsen, K.
    Ollivett, T. L.
    JOURNAL OF DAIRY SCIENCE, 2020, 103 (10) : 9464 - 9472
  • [40] A novel risk assessment tool for bovine respiratory disease in preweaned dairy calves
    Maier, G. U.
    Love, W. J.
    Karle, B. M.
    Dubrovsky, S. A.
    Williams, D. R.
    Champagne, J. D.
    Anderson, R. J.
    Rowe, J. D.
    Lehenbauer, T. W.
    Van Eenennaam, A. L.
    Aly, S. S.
    JOURNAL OF DAIRY SCIENCE, 2020, 103 (10) : 9301 - 9317